• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluating Disparities in Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplant Treatment Using Geospatial and Social Vulnerability Analytic Tools.

作者信息

Mehta Nirja, Little Keighly, Woodworth Michael H, Goodenough Dana, Dhonau Robin, Fridkin Scott K

机构信息

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Georgia Emerging Infections Program, Atlanta, Georgia; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

出版信息

Gastroenterology. 2025 Jun 11. doi: 10.1053/j.gastro.2025.05.028.

DOI:10.1053/j.gastro.2025.05.028
PMID:40505989
Abstract
摘要

相似文献

1
Evaluating Disparities in Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplant Treatment Using Geospatial and Social Vulnerability Analytic Tools.使用地理空间和社会脆弱性分析工具评估复发性艰难梭菌感染和粪便微生物群移植治疗中的差异。
Gastroenterology. 2025 Jun 11. doi: 10.1053/j.gastro.2025.05.028.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌（艰难梭菌）。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Infection in Rural Hospitals?粪便微生物移植在农村医院治疗复发性感染中的作用？
Front Public Health. 2021 Jun 9;9:670941. doi: 10.3389/fpubh.2021.670941. eCollection 2021.
4
Host origin of microbiota drives functional recovery and clearance in mice.微生物群的宿主来源驱动小鼠的功能恢复和清除。
mBio. 2025 Jun 2:e0110825. doi: 10.1128/mbio.01108-25.
5
Fecal microbiota live - jslm (Rebyota™/RBL) for management of recurrent infection.用于治疗复发性感染的粪便微生物群活菌制剂-jslm（Rebyota™/RBL）
Future Microbiol. 2024;19(14):1243-1251. doi: 10.1080/17460913.2024.2364583. Epub 2024 Jul 11.
6
Microbiome Therapeutics for Clostridioides difficile Infection.用于艰难梭菌感染的微生物组疗法
Infect Dis Clin North Am. 2025 Aug 11. doi: 10.1016/j.idc.2025.07.007.
7
Fecal Microbiome Transplantation for Recurrent CDI: Treatment Efficacy and Safety with Oral Capsules.粪便微生物群移植治疗复发性艰难梭菌感染：口服胶囊的治疗效果与安全性
J Gastrointestin Liver Dis. 2025 Jun 28;34(2):199-204. doi: 10.15403/jgld-5990.
8
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS.用于预防PUNCH CD3-OLS中炎症性肠病患者复发性艰难梭菌感染的活粪微生物群制剂-jslm（REBYOTA®）的安全性和有效性
Inflamm Bowel Dis. 2025 Jan 25. doi: 10.1093/ibd/izae291.
9
Effectiveness and Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Immunocompromised Patients.
Clin Gastroenterol Hepatol. 2025 Aug 7. doi: 10.1016/j.cgh.2025.06.043.
10
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA®) for Preventing Recurrent Clostridioides difficile Infection.给予粪便微生物群制剂Live-jslm（REBYOTA®）预防艰难梭菌反复感染后微生物组和代谢组的恢复
J Infect Dis. 2024 Aug 22. doi: 10.1093/infdis/jiae418.